Yuyu Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	29,091	41,832	30,605	25,839	50,263
Trading Asset Securities	3,614	817.27	1,749	4,939	-
Cash & Short-Term Investments	32,705	42,650	32,354	30,778	50,263
Cash Growth	-23.32%	31.82%	5.12%	-38.77%	145.15%
Accounts Receivable	18,553	17,662	20,801	21,940	19,528
Other Receivables	1,329	2,069	3,653	2,876	3,265
Receivables	19,882	19,731	24,455	24,816	22,793
Inventory	42,221	38,628	44,152	39,832	25,225
Prepaid Expenses	940.94	327.71	341.03	238.84	115.08
Other Current Assets	1,166	611.32	294.62	692.94	491.06
Total Current Assets	96,914	101,947	101,597	96,358	98,888
Property, Plant & Equipment	93,457	89,987	81,403	81,371	80,341
Long-Term Investments	10,217	8,626	6,867	5,944	5,712
Goodwill	153.77	153.77	503.22	50.83	50.83
Other Intangible Assets	2,680	2,977	3,764	3,666	4,087
Long-Term Accounts Receivable	-	-	-0	493.76	345.28
Long-Term Deferred Tax Assets	1,028	909.48	-	-	-
Other Long-Term Assets	2,673	2,988	4,079	6,826	3,561
Total Assets	207,223	207,687	198,214	195,205	192,985
Accounts Payable	9,377	9,475	10,952	15,841	8,982
Accrued Expenses	1,416	1,494	1,504	1,613	1,553
Short-Term Debt	27,191	31,186	24,482	36,164	8,200
Current Portion of Long-Term Debt	33.32	1,475	448.73	718.28	1,812
Current Portion of Leases	441.66	581.1	455.55	542.86	414.94
Current Income Taxes Payable	780.6	1,043	574.8	297.04	219.32
Other Current Liabilities	19,708	19,226	11,558	9,140	8,832
Total Current Liabilities	58,948	64,480	49,975	64,316	30,015
Long-Term Debt	-	33.32	13,640	1,600	28,456
Long-Term Leases	256.52	369.17	380.92	250.96	282.81
Pension & Post-Retirement Benefits	3,103	2,859	2,286	1,732	2,491
Long-Term Deferred Tax Liabilities	3,581	4,094	4,360	3,690	2,897
Other Long-Term Liabilities	791.74	788.34	7,215	242.12	158.07
Total Liabilities	66,679	72,624	77,858	71,831	64,300
Common Stock	17,609	17,609	17,609	17,609	17,609
Additional Paid-In Capital	64,684	64,981	65,075	58,803	58,803
Retained Earnings	32,498	25,789	20,171	31,396	36,540
Treasury Stock	-7,788	-5,791	-5,791	-6,156	-4,371
Comprehensive Income & Other	20,036	20,050	12,531	12,572	13,107
Total Common Equity	127,039	122,639	109,595	114,224	121,689
Minority Interest	10,913	9,831	8,168	6,558	4,404
Shareholders' Equity	140,544	135,063	120,356	123,374	128,685
Total Liabilities & Equity	207,223	207,687	198,214	195,205	192,985
Total Debt	27,923	33,644	39,407	39,276	39,166
Net Cash (Debt)	4,783	9,005	-7,053	-8,499	11,097
Net Cash Growth	-46.89%	-	-	-	1907.08%
Net Cash Per Share	282.12	529.76	-433.55	-512.57	695.34
Filing Date Shares Outstanding	16.15	16.18	16.18	16.35	16.66
Total Common Shares Outstanding	16.15	16.18	16.18	16.35	16.66
Working Capital	37,967	37,468	51,621	32,042	68,873
Book Value Per Share	7864.40	7578.44	6772.38	6985.77	7306.09
Tangible Book Value	124,205	119,509	105,327	110,506	117,551
Tangible Book Value Per Share	7688.94	7384.99	6508.66	6758.42	7057.65
Land	39,962	39,962	30,380	30,380	30,380
Buildings	54,561	53,192	53,397	52,138	48,966
Machinery	44,578	42,217	39,229	37,067	33,334
Construction In Progress	3,686	385.8	259.36	1,333	3,454

Source: S&P Global Market Intelligence. Standard template. Financial Sources.